Controversial hypertension guidelines raise risk of kidney failure and syncope.
Many patients with mitral valve disease are referred too late and receive treatment only after heart or lung damage has occurred, researchers say.
The rates of myocardial infarction (MI) diagnosis and treatment increased after the introduction of high-sensitivity cardiac troponins (hs-cTnT), with no impact on overall survival, researchers report.
Neither fish nor fowl: What works for HF patients with borderline ejection fraction?
Debate heats up on whether HF Is Linked to Increased Cancer Incidence.
Oussama Wazni, MD, section head of clinical cardiac electrophysiology at Cleveland Clinic, discusses which treatments are best for patients who exhibit symptoms of atrial fibrillation.
Do LVADs offer the same mortality benefits in patients with both heart failure and end-stage renal disease? A new study explores the question.
ACC 2018: COMPASS Trial Finds Combination of Rivaroxaban & Aspirin Significantly Lowers Major Adverse Limb Events in Patients With PAD
COMPASS trial finds that a combination of rivaroxaban and aspirin are more effective for PAD patients than aspirin alone.
New guidelines dramatically increase the number of patients with hypertension. Do they all need medication?
A new study finds that patients who go into in-hospital cardiac arrest (IHCA) during the weekend have a lower chance of survival compared to those who are admitted to the hospital during a weekday.
According to the American College of Cardiology, ablation is the first-line treatment for atrial fibrillation. Dr. Oussama Wazni weighs the pros and cons of this treatment option.
- Use the CHA2DS2-VASc score for determining which patients are at greatest risk of stroke.
- Clinicians should take an individualized approach to antithrombotic therapy.
- Strict rate control is preferred over lenient.
- Catheter ablation is a first-line option.
Managing atrial fibrillation to prevent stroke: Use nothing or an oral anticoagulant. Use the CHA2DS2-VASc algorithm as well as gender to determine treatment choices. Dr. Wazni presents treatment choices in further detail.
Patients with atrial fibrillation are seen with increasing frequency by clinicians. Can it be cured? How must it be managed? How can clinicians prevent stroke in patients with a-fib? Dr. Wazni addresses these questions in our latest video.
- New multinational study of more than 500 patients found no clear superiority of either strategy.
- The incidence of serious thromboembolic events was low, 2%, and did not differ between the arms.
- More patients in the rate control arm met protocol-specified indications for anticoagulation compared with the rhythm control arm.